MicroRNA-205 regulates HER3 in human breast cancer

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2195-2200

  Iorio, Marilena V ^a   Casalini, Patrizia ^a   Piovan, Claudia ^a   Leva, Gianpiero Di ^b   Merlo, Andrea ^a   Triulzi, Tiziana ^a   Ménard, Sylvie ^a   Croce, Carlo M ^b   Tagliabue, Elda ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEFITINIB; LAPATINIB; MICRORNA; PROTEIN KINASE B BETA; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MIRN205 MICRORNA, HUMAN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; QUINAZOLINE DERIVATIVE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CARCINOGENESIS; CELL PROLIFERATION; CLONOGENESIS; DRUG ACTIVITY; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CELL GROWTH; DRUG ANTAGONISM; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; MULTIMODALITY CANCER THERAPY; PATHOLOGY; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; GENE THERAPY; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; ONCOGENE PROTEIN V-AKT; QUINAZOLINES; RECEPTOR, ERBB-3; TRANSFECTION;

EID: 65549110881     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2920     Document Type: Article

References (20)

1. Calirt GA, Croce CM. MieroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-66.
2. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120: 635-47.
3. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102:13944-9.
4. Voorhoeve PM, le Sage C, Schrier M, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006; 124:1169-81.
5. lorio MV, Ferracin M, Liu CG, et al. microRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-70.
6. Iorio MV, Casalini P, Tagliabue E, Ménard S, Croce CM. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 2008;44:2753-9.
7. Zhu S, Si ML, Wu F£ Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1), J Biol Chem 2007;282:14328-36.
8. Rrankel LB, Christoffersen MR, Jacobsen A, et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR- 21 in breast cancer cells. J Biol Chem 200B;283: 1026-33.
9. Ma L, Teruya-Feldstein J, Weinberg RA. Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007;449:682-8.
10. Scott GK, Goga A, Bhaumik D, et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 2007;282:1479-86.
11. Sempere LF, Christensen Mette, Silahtaroglu A, et al. Altered MicroRKA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 2007;67:11612-20.
12. Gregory' PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10: 593-601.
13. Ménard S, Casalini P, Campiglio M, Pupa SM, Tagliabue E. Role of HER2/neu in tumor progression and therapy. Cell Mol Life Sei 2004; 61:2965-78.
14. Casalini P, lorio MV, Galmozzi E, Ménard S. Role of HER receptors family in development and differentiation, J Cell Physiol 2004;200:343-50.
15. Iorio MV, Visone R, Di Leva G, et al. microRNA signatures in human ovarian cancer. Cancer Res 2007; 67:8699-707.
16. Visone R, Russo L, Pallante P, et al. MicroRMAs (miR)- 221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kipl protein levels and cell cycle. Endocr Relat Cancer 2007;14:791-8.
17. Megraw M, Sethupathy P( Corda B, Hatzigeorgiou AG. miRGen: a database for the study of animal mieroRNA genomic organization and function. Nucleic Acids Res 2007;35:0146-55.
18. Alimandi M, Romano A, Curia MC, et al. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 1995; 10:1813-21.
19. Hsieh AC, Moasser MM. Targeting HER proteins in cancer therapy and the role of the non-target HER3. Br J Cancer 2007;97:453-7.
20. Sergina NV, Rausch M, Wang D, et al. Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3. Nature 2007;445:437-41.